Evidence map›Paper›PMID 26937186›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2016

COPD: the patient perspective.

Paul W Jones, Henrik Watz, Emiel F M Wouters, Mario Cazzola

Registry-linked trialOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05922293 (Combined Effects of Blow Bottle Technique and Percussion Technique in Patients With Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05922293 nacompletednot on this mapstarted 2023, after this paper: background citation

Combined Effects of Blow Bottle Technique and Percussion Technique in Patients With Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorRiphah International UniversityRan2023 to 2023Enrolled30ConditionsChronic Obstructive Pulmonary DiseaseArmsblow bottle, percussion
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Fractional Dynamics Foster Deep Learning of COPD Stage Prediction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. Article
  10. Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study.International journal of chronic obstructive pulmonary disease · 2020
    Article
  11. Review
  12. Observational
  13. Article
  14. Review
  15. Patient-perceived treatment burden of chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2017
    Article
  16. Article
  17. Observational
  18. Review
  19. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Paul W JonesDivision of Clinical Science, St George's, University of London, London, UK.
Henrik WatzPulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
Emiel F M WoutersCIRO+, Department of Respiratory Medicine, Maastricht University, Maastricht, the Netherlands.
Mario CazzolaUnit of Respiratory Clinical Pharmacology, Department of Systemic Medicine, University of Rome 'Tor Vergata,' Rome, Italy.
LungenClinic Grosshansdorf · DEMaastricht University · NLSt George's, University of London · GBUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease characterized by nonreversible airway obstruction. Well-characterized symptoms such as exertional dyspnea and fatigue have a negative impact on patients' quality of life (QoL) and restrict physical activity in daily life. The impact of COPD symptoms on QoL is often underestimated; for example, 36% of patients who describe their symptoms as being mild-to-moderate also admit to being too breathless to leave the house. Additionally, early morning and nighttime symptoms are a particular problem. Methods are available to allow clinicians to accurately assess COPD symptoms, including patient questionnaires. Integrated approaches to COPD management, particularly pulmonary rehabilitation, are effective strategies for addressing symptoms, improving exercise capacity and, potentially, also increasing physical activity. Inhaled bronchodilators continue to be the mainstay of drug therapy in COPD, where options can be tailored to meet patients' needs with careful selection of the inhaled medication and the device used for its delivery. Overall, an integrated approach to disease management should be considered for improving QoL and subsequent patient outcomes in COPD.

Indexed as

Patient-Centered CareBronchodilator AgentsCost of IllnessExercise ToleranceHealth StatusHumansLungPredictive Value of TestsPulmonary Disease, Chronic ObstructiveQuality of LifeRecovery of FunctionTreatment OutcomeBronchodilator AgentsCOPDpatientsphysical activity levelspulmonary rehabilitation

Identifiers

PMID26937186
PMCPMC4764028
OpenAlexW2282986297

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.